LEVODOPA + BENSERAZIDE
levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100
LEVODOPA + BENSERAZIDE (14356N)
14356N
Body System:
Manner of administration:Oral
Restriction
Indication: The condition must be stable for the prescriber to consider the listed maximum quantity
of this medicine suitable for this patient.
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 200 | # of repeats: 5 | DPMQ: $37.22 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Madopar Rapid 62.5 | |||||